Description:
H.R. 4982 would direct the Government Accountability Office (GAO) to conduct an evaluation of the infrastructure for treating opioid and other substance abuse in the United States. The bill would require GAO to submit a report to the Congress on the evaluation no later than 24 months after the date of enactment.
The evaluation would assess the capacity of detoxification and stabilization programs, transitional residential support services, residential rehabilitation programs, and demographic-specific treatment programs. The evaluation also would measure any geographical differences in the treatment infrastructure and the need for residential and outpatient treatment for substance use disorders. GAO’s report would include an assessment of the availability of certain treatment programs and detail any barriers to real-time reporting of information on drug overdoses.
CBO estimates that implementing H.R. 4982 would cost less than $500,000 over the 2017-2021 period; any such spending would be subject to the availability of appropriated funds. Pay-as-you-go procedures do not apply to this legislation because it would not affect direct spending or revenues.
CBO estimates that enacting H.R. 4982 would not increase direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2027.
H.R. 4982 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act and would impose no costs on state, local, or tribal governments.
